Reducing red blood cell transfusion in orthopedic and cardiac surgeries with Antifibrinolytics: A laboratory medicine best practice systematic review and meta-analysis

Clinical Biochemistry

Volumn 71, Issue , 2019, Pages 1-13

  Derzon, James H ^a   Clarke, Nicole ^b,g   Alford, A ^c   Gross, I ^d   Shander, A ^e   Thurer, Robert ^f  

^a RTI INTERNATIONAL   (United States)

^b PHARMERIT INTERNATIONAL   (United States)

^c Research and Evaluation   (United States)

^d Acumen   (United States)

^e ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^f Gauss Surgical Inc   (United States)

^g Vector Oncology   (United States)

Author keywords

Antifibrinolytics; Meta analysis; Red blood cell transfusion; Systematic review; Tranexamic acid; Aminocaproic acid

Indexed keywords

AMINOCAPROIC ACID; APROTININ; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

CINAHL; COMPARATIVE STUDY; DOSE RESPONSE; EMBASE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; HEART SURGERY; HUMAN; MEDLINE; META ANALYSIS; ORTHOPEDIC SURGERY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; LABORATORY;

ANTIFIBRINOLYTIC AGENTS; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; HUMANS; LABORATORIES; ORTHOPEDIC PROCEDURES; PRACTICE GUIDELINES AS TOPIC;

EID: 85068467430     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2019.06.015     Document Type: Review

References (131)

1. Lerman, D.M., Rapp, T.B., Minimizing blood loss in orthopaedic surgery: the role of antifibrinolytics. Bull. Hosp. Jt Dis. 73:2 (2015), 83–89.
2. Carling, M.S., Jeppsson, A., Eriksson, B.I., Brisby, H., Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J. Orthop. Surg. Res., 10(1), 2015.
3. Task Force on Perioperative Blood Management, Practice guidelines for perioperative blood management: An updated report by the American Society of Anesthesiologists Anesthesiology 122:2 (2015), 241–275.
4. Shander, A., Gross, I., Hill, S., Javidroozi, M., Sledge, S., A new perspective on best transfusion practices. Blood Transfus. 11:2 (2013), 193–202.
5. Drew, V.J., Barro, L., Seghatchian, J., Burnouf, T., Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries. Blood Transfus., 15(6), 2017, 512.
6. Spahn, D.R., Goodnough, L.T., Alternatives to blood transfusion. Lancet 381:9880 (2013), 1855–1865.
7. Cardone, D., Klein, A.A., Perioperative blood conservation. Eur. J. Anaesthesiol. 26:9 (2009), 722–729.
8. Royston, D., The current place of aprotinin in the management of bleeding. Anaesthesia 70 (2014), 46–e17.
9. Fergusson, D.A., Hébert, P.C., Mazer, C.D., Fremes, S., MacAdams, C., Murkin, J.M., Teoh, K., Duke, P.C., Arellano, R., Blajchman, M.A., A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N. Engl. J. Med. 358:22 (2008), 2319–2331.
10. Hébert, P.C., Fergusson, D.A., Hutton, B., Mazer, C.D., Fremes, S., Blajchman, M., MacAdams, C., Wells, G., Robblee, J., Bussieres, J., Teoh, K., Regulatory decisions pertaining to aprotinin may be putting patients at risk. Can. Med. Assoc. J. 186:18 (2014), 1379–1386.
11. Ortmann, E., Besser, M., Klein, A., Antifibrinolytic agents in current anaesthetic practice. Br. J. Anaesth. 111:4 (2013), 549–563.
12. EMA, European Medicines Agency Recommends Lifting Suspension of Aprotinin 2012. https://goo.gl/uV7m7N Accessed 12/17/2018.
13. Falana, O., Patel, G., Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery. Ann. Pharmacother. 48:12 (2014), 1563–1569.
14. Churchill, J., Puca, K., Meyer, E., Carleton, M., Anderson, M., Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. J. Knee Surg. 30:05 (2016), 460–466.
15. Christenson, R.H., Snyder, S.R., Shaw, C.S., Derzon, J.H., Black, R.S., Mass, D., Epner, P., Favoretto, A.M., Liebow, E.B., Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement. Clin. Chem. 57:6 (2011), 816–825.
16. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., Schunemann, H.J., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:7650 (2008), 924–926.
17. Derzon, J., Alford, A., Clarke, N., Gross, I., Shander, A., Thurer, R., Anemia management and audit feedback practices for reducing overuse of RBC transfusion: a laboratory medicine best practice systematic review and meta-analysis. Am. J. Clin. Pathol. 151:1 (2019), 18–28.
18. Aguilera, X., Videla, S., Aimenara, M., Fernandez, J.A., Gich, I., Cieaya, F., Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop. Belg., 78(1), 2012, 68.
19. Álvarez, J.C., Santiveri, F.X., Ramos, I., Vela, E., Puig, L., Escolano, F., Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion (Paris) 48:3 (2008), 519–525.
20. Aslam, K.S., Niazi, A.K., Nabi, O., Efficacy of tranexamic acid in reducing blood loss in total knee replacements. J. Pak. Med. Assoc. 65:11 Suppl 3 (2015), S210–S214.
21. Bagsby, D.T., Samujh, C.A., Vissing, J.L., Empson, J.A., Pomeroy, D.L., Malkani, A.L., Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral total knee arthroplasty. J. Arthroplast. 30:12 (2015), 2106–2109.
22. Baker, J.E., Pavenski, K., Pirani, R.A., White, A., Kataoka, M., Waddell, J.P., Ho, A., Schemitsch, E.H., Lo, N., Bogoch, E.R., Pronovost, A., Luke, K., Howell, A., Nassis, A., Tsui, A.K.Y., Tanzini, R.M., Pulendrarajah, R., Mazer, C.D., Freedman, J., Hare, G.M.T., Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation. Can. J. Anaesth. 62:11 (2015), 1179–1187.
23. Camarasa, M.A., Ollé, G., Serra-Prat, M., Martín, A., Sánchez, M., Ricós, P., Pérez, A., Opisso, L., Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br. J. Anaesth. 96:5 (2006), 576–582.
24. Charoencholvanich, K., Siriwattanasakul, P., Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin. Orthop. Relat. Res. 469:10 (2011), 2874–2880.
25. Claeys, M.A., Vermeersch, N., Haentjens, P., Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir. Belg. 107:4 (2007), 397–401.
26. Craik, J.D., Ei Shafie, S.A., Kidd, A.G., Twyman, R.S., Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains?. Eur. J. Orthop. Surg. Traumatol. 24:3 (2013), 379–384.
27. Diprose, P., Herbertson, M.J., O'Shaughnessy, D., Deakin, C.D., Gill, R.S., Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br. J. Anaesth. 94:3 (2005), 271–278.
28. Endres, S., Heinz, M., Wilke, A., Efficacy of tranexamic acid in reducing blood loss in posterior lumbar spine surgery for degenerative spinal stenosis with instability: A retrospective case control study. BMC Surg., 11(1), 2011.
29. Gautam, V.K., Sambandam, B., Singh, S., Gupta, P., Gupta, R., Maini, L., The role of tranexamic acid in reducing blood loss in total knee replacement. J. Clin. Orthop. Trauma 4:1 (2013), 36–39.
30. Greiff, G., Stenseth, R., Wahba, A., Videm, V., Lydersen, S., Irgens, W., Bjella, L., Pleym, H., Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial. J. Cardiothorac. Vasc. Anesth. 26:2 (2012), 232–238.
31. Hogan, C.A., Golightly, L.K., Phong, S., Dayton, M.R., Lyda, C., Barber, G.R., Perioperative blood loss in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med., 4, 2016 205031211663702.
32. Huang, G.-P., Jia, X.-F., Xiang, Z., Ji, Y., Wu, G.-Y., Tang, Y., Li, J., Zhang, J., Tranexamic acid reduces hidden blood loss in patients undergoing total knee arthroplasty: a comparative study and meta-analysis. Med. Sci. Monit. 22 (2016), 797–802.
33. Johansson, T., Pettersson, L., Lisander, B., Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 76:3 (2005), 314–319.
34. Karski, J., Djaiani, G., Carroll, J., Iwanochko, M., Seneviratne, P., Liu, P., Kucharczyk, W., Fedorko, L., David, T., Cheng, D., Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. J. Thorac. Cardiovasc. Surg. 130:2 (2005), 309–314.
35. Karam, J.A., Bloomfield, M.R., DiIorio, T.M., Irizarry, A.M., Sharkey, P.F., Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J. Arthroplast. 29:3 (2014), 501–503.
36. Kazemi, S.M., Mosaffa, F., Eajazi, A., Kaffashi, M., Besheli, L.D., Bigdeli, M.R., Zanganeh, R.F., The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics 33:1 (2010), 17–22.
37. Kim, T.K., Chang, C.B., Kang, Y.G., Seo, E.S., Lee, J.H., Yun, J.H., Lee, S.H., Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg. Sports Traumatol. Arthrosc. 22:8 (2014), 1870–1878.
38. Kopanidis, P., Hardidge, A., McNicol, L., Tay, S., McCall, P., Weinberg, L., Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty. J. Orthop. Surg. Res., 11(1), 2016.
39. Kumar, S., Randhawa, M.S., Ganesamoni, R., Singh, S.K., Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. J. Urol. 189:5 (2013), 1757–1761.
40. Later, A.F.L., Maas, J.J., Engbers, F.H.M., Versteegh, M.I.M., Bruggemans, E.F., Dion, R.A.E., Klautz, R.J.M., Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial☆. Eur. J. Cardiothorac. Surg. 36:2 (2009), 322–329.
41. Liu, K.-L., Chen, I.-H., Wen, S.-H., Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: a population-based study in Taiwan. J. Formos. Med. Assoc. 116:1 (2017), 24–31.
42. Lozano, M., Basora, M., Peidro, L., Merino, I., Segur, J.M., Pereira, A., Salazar, F., Cid, J., Lozano, L., Mazzara, R., Macule, F., Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang. 95:1 (2008), 39–44.
43. MacGillivray, R.G., Tarabichi, S.B., Hawari, M.F., Raoof, N.T., Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty. J. Arthroplast. 26:1 (2011), 24–28.
44. Maniar, R.N., Kumar, G., Singhi, T., Nayak, R.M., Maniar, P.R., Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin. Orthop. Relat. Res. 470:9 (2012), 2605–2612.
45. McGoldrick, N.P., Cost benefit analysis of the use of tranexamic acid in primary lower limb arthroplasty: a retrospective cohort study. World J. Orthop., 6(11), 2015, 977.
46. Mohib, Y., Rashid, R.H., Ali, M., Zubairi, A.J., Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J. Pak. Med. Assoc., 65(11), 2015, S17.
47. Molloy, D.O., Archbold, H.A.P., Ogonda, L., McConway, J., Wilson, R.K., Beverland, D.E., Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement. J. Bone Joint Surg. (Br.) 89-B:3 (2007), 306–309.
48. Mutsuzaki, H., Ikeda, K., Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J. Orthop. Surg. Res., 7(1), 2012, 32.
49. Niskanen, R.O., Korkala, O.L., Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop. 76:6 (2005), 829–832.
50. Orpen, N.M., Little, C., Walker, G., Crawfurd, E.J.P., Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13:2 (2006), 106–110.
51. Ortega-Andreu, M., Talavera, G., Padilla-Eguiluz, N.G., Perez-Chrzanowska, H., Figueredo-Galve, R., Rodriguez-Merchán, C.E., Gómez-Barrena, E., Tranexamic acid in a multimodal blood loss prevention protocol to decrease blood loss in revision total knee arthroplasty: a cohort study. Open Orthop. J. 10:1 (2016), 439–447.
52. Pongcharoen, B., Ruetiwarangkoon, C., Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty?. J. Orthop. Sci. 21:2 (2016), 211–215.
53. Rajesparan, K., Biant, L.C., Ahmad, M., Field, R.E., The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J. Bone Joint Surg. (Br.) 91-B:6 (2009), 776–783.
54. Ralley, F.E., Berta, D., Binns, V., Howard, J., Naudie, D.D.R., One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin. Orthop. Relat. Res. 468:7 (2010), 1905–1911.
55. Raviraj, A., Anand, A., Chakravarthy, M., Kumarswamy, S., Prabhu, A., Pai, S., Tranexamic acid reduces blood loss in simultaneous bilateral total knee arthroplasty: a randomized control trial. Eur. J. Orthop. Surg. Traumatol. 22:5 (2011), 381–386.
56. Santos, A.T.L., Kalil, R.A.K., Bauemann, C., Pereira, J.B., Nesralla, I.A., A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Braz. J. Med. Biol. Res. 39:1 (2006), 63–69.
57. Sepah, Y.J., Umer, M., Ahmad, T., Nasim, F., Umer Chaudhry, M., Umar, M., Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J. Orthop. Surg. Res., 6(1), 2011, 22.
58. Shi, J., Ji, H., Ren, F., Wang, G., Xu, M., Xue, Y., Chen, M., Qi, J., Li, L., Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting. JAMA Surg., 148(6), 2013, 538.
59. Taghaddomi, R.J., Mirzaee, A., Attar, A.S., Shirdel, A., Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J. Cardiothorac. Vasc. Anesth. 23:3 (2009), 312–315.
60. Volquind, D., Zardo, R.A., Winkler, B.C., Londero, B.B., Zanelatto, N., Leichtweis, G.P., Use of tranexamic acid in primary total knee replacement: effects on perioperative blood loss. Braz. J. Anesthesiol. 66:3 (2016), 254–258.
61. Wang, C., Kang, P., Ma, J., Yue, C., Xie, J., Pei, F., Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb. Res. 141 (2016), 119–123.
62. Alshryda, S., Mason, J., Sarda, P., Nargol, A., Cooke, N., Ahmad, H., Tang, S., Logishetty, R., Vaghela, M., McPartlin, L., Hungin, A.P.S., Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement. J. Bone Joint Surg. Am. 95:21 (2013), 1969–1974.
63. Chen, J.Y., Chin, P.L., Moo, H., Pang, H.N., Tay, D.K.J., Chia, S.-L., Lo, N.N., Yeo, S.J., Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee 23:1 (2016), 152–156.
64. Goyal, N., Chen, D.B., Harris, I.A., Rowden, N., Kirsh, G., MacDessi, S.J., Clinical and financial benefits of intra-articular tranexamic acid in total knee arthroplasty. J. Orthop. Surg. (Hong Kong) 24:1 (2016), 3–6.
65. Onodera, T., Majima, T., Sawaguchi, N., Kasahara, Y., Ishigaki, T., Minami, A., Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J. Arthroplast. 27:1 (2012), 105–108.
66. Oztas, S., Ozturk, A., Akalin, Y., Sahin, N., Ozkan, Y., Otuzbir, A., Avcu, B., The effect of local and systemic application of tranexamic acid on the amount of blood loss and allogeneic blood transfusion after total knee replacement. Acta Orthop. Belg. 81:4 (2015), 698–707.
67. Sa-ngasoongsong, P., Channoom, T., Kawinwonggowit, V., Woratanarat, P., Chanplakorn, P., Wibulpolprasert, B., Wongsak, S., Udomsubpayakul, U., Wechmongkolgorn, S., Lekpittaya, N., Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop. Rev. (Pavia), 3(2), 2011, 12.
68. Tahmasebi, M.N., Bashti, K., Ghorbani, G., Sobhan, M.R., Intraarticular administration of tranexamic acid following total knee arthroplasty: a case-control study. Arch. Bone Jt. Surg., 2(3), 2014, 141.
69. Xu, X., Li, X., Liu, W., Wang, Z., Longtime soaking of high concentration tranexamic acid in total hip arthroplasty: a prospective randomized controlled trial in 224 patients. Pak. J. Med. Sci. 31:6 (2015), 1306–1311.
70. Georgiadis, A.G., Muh, S.J., Silverton, C.D., Weir, R.M., Laker, M.W., A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J. Arthroplast. 28:8 (2013), 78–82.
71. Konig, G., Hamlin, B.R., Waters, J.H., Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J. Arthroplast. 28:9 (2013), 1473–1476.
72. Martin, J.G., Cassatt, K.B., Kincaid-Cinnamon, K.A., Westendorf, D.S., Garton, A.S., Lemke, J.H., Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J. Arthroplast. 29:5 (2014), 889–894.
73. Wind, T.C., Barfield, W.R., Moskal, J.T., The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J. Arthroplast. 28:7 (2013), 1080–1083.
74. Berenholtz, S.M., Pham, J.C., Garrett-Mayer, E., Atchison, C.W., Kostuik, J.P., Cohen, D.B., Nundy, S., Dorman, T., Ness, P.M., Klag, M.J., Pronovost, P.J., Kebaish, K.M., Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. Spine (Phila Pa 1976) 34:19 (2009), 2096–2103.
75. Kikura, M., Levy, J.H., Tanaka, K.A., Ramsay, J.G., A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J. Am. Coll. Surg. 202:2 (2006), 216–222.
76. Kreisler, K.R., Vance, R.A., Cruzzavala, J., Mahnken, J.D., Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery. J. Cardiothorac. Vasc. Anesth. 19:5 (2005), 608–611.
77. Cohen, J., Statistical Power Analysis for the Behavioral Sciences. 1988, Hillsdale, NJ, Earlbaum.
78. Raudenbush, S.W., Random effects models. Cooper, H., Hedges, L.V., (eds.) The Handbook of Research Synthesis, 1994, Russell Sage, New York, NY, 301–321.
79. Hunter, J.E., Schmidt, F.L., Fixed effects vs. random effects meta-analysis models: implications for cumulative research knowledge. Int. J. Select Assess. 8:4 (2000), 275–292.
80. Higgins, J.P.T., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat. Med. 21:11 (2002), 1539–1558.
81. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
82. Engelbrecht, S., Wood, E.M., Cole-Sinclair, M.F., Clinical transfusion practice update: Haemovigilance, complications, patient blood management and national standards. Med. J. Aust. 199:6 (2013), 397–401.
83. National Institute for Health and Care Excellence (NICE), Detecting, Managing and Monitoring Haemostasis: Viscoelastometric Point-of-Care Testing (ROTEM, TEG, and Sonoclot systems). https://bit.ly/2K00ULw, 2014 Accessed 01/23/2019.
84. Hunt, H., Stanworth, S., Curry, N., Woolley, T., Cooper, C., Ukoumunne, O., Zhelev, Z., Hyde, C., Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma-induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst. Rev.(2), 2015.
85. Sankarankutty, A., Nascimento, B., da Luz, L.T., Rizoli, S., TEG® and ROTEM® in trauma: similar test but different results?. World J. Emerg. Surg., BioMed. Central, 2012, S3.
86. The Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris, V.A., Ferraris, S.P., Saha, S.P., Hessel, E.A. II, Haan, C.K., Royston, B.D., Bridges, C.R., Higgins, R.S., Despotis, G., Brown, J.R., Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann. Thorac. Surg. 83:5 (2007), S27–S86.
87. M. McEvoy, Tranexamic Acid (TXA): Drug Whys: A Comprehensive Examination of TXA, the Support for Its Prehospital Use, and Off-Label Administration of TXA by EMS for Trauma Patients with Major Hemorrhage, 2018. https://goo.gl/LGXaSQ. (Accessed 12/13/2018).
88. Muschart, X., Vincent, P., What's new for tranexamic acid?. J. Emerg. Med. 51:3 (2016), 332–333.
89. Blaine, K.P., Press, C., Lau, K., Sliwa, J., Rao, V.K., Hill, C., Comparative effectiveness of epsilon-aminocaproic acid and tranexamic acid on postoperative bleeding following cardiac surgery during a national medication shortage. J. Clin. Anesth. 35 (2016), 516–523.
90. Henry, D.A., Carless, P.A., Moxey, A.J., O'Connell, D., Stokes, B.J., Fergusson, D.A., Ker, K., Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst. Rev., 3, 2011, CD001886.
91. Brown, J.R., Birkmeyer, N., O'Connor, G.T., Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115:22 (2007), 2801–2813.
92. Levi, M., Cromheecke, M.E., de Jonge, E., Prins, M.H., de Mol, B.J., Briët, E., Büller, H.R., Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:9194 (1999), 1940–1947.
93. Laupacis, A., Fergusson, D., Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth. Analg. 85:6 (1997), 1258–1267.
94. Cheriyan, T., Maier, S.P. II, Bianco, K., Slobodyanyuk, K., Rattenni, R.N., Lafage, V., Schwab, F.J., Lonner, B.S., Errico, T.J., Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J. 15:4 (2015), 752–761.
95. Song, G., Yang, P., Hu, J., Zhu, S., Li, Y., Wang, Q., The effect of tranexamic acid on blood loss in orthognathic surgery: a meta-analysis of randomized controlled trials. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 115:5 (2013), 595–600.
96. Wang, C., Xu, G.-j., Han, Z., Ma, J.-x., Ma, X.-l., Jiang, X., Wang, Y., Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis. Int. J. Surg. 15 (2015), 134–139.
97. Alshryda, S., Sarda, P., Sukeik, M., Nargol, A., Blenkinsopp, J., Mason, J., Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J. Bone Joint Surg. 93:12 (2011), 1577–1585 British volume.
98. Ng, W.C.K., Jerath, A., Wasowicz, M., Tranexamic acid: a clinical review. Anaesthesiol. Intensive Ther. 47:4 (2015), 339–350.
99. Perel, P., Ker, K., Morales Uribe, C.H., Roberts, I., Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst. Rev., 1(1), 2013, CD010245.
100. Dhir, A., Antifibrinolytics in cardiac surgery. Ann. Card. Anaesth., 16(2), 2013, 117.
101. Pabinger, I., Fries, D., Schöchl, H., Streif, W., Toller, W., Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien. Klin. Wochenschr. 129:9–10 (2017), 303–316.
102. Rossaint, R., Bouillon, B., Cerny, V., Coats, T.J., Duranteau, J., Fernández-Mondéjar, E., Hunt, B.J., Komadina, R., Nardi, G., Neugebauer, E., Management of bleeding following major trauma: an updated European guideline. Crit. Care, 14(2), 2010, R52.
103. Goodnough, L.T., Shander, A., Current status of pharmacologic therapies in patient blood management. Anesth. Analg. 116:1 (2013), 15–34.
104. Food and Drug Administration, Highlights of Prescribing Information: Lysteda (Tranexamic Acid) Tablets. https://goo.gl/ZEuRB9, 2018 Accessed 08/18/2018.
105. Food and Drug Administration, Drugs@FDA: FDA Approved Drug Products: Amicar NDA 15–197/S-036, 037, 038, 039. https://goo.gl/EbcyDG, 2018 Accessed 12/13/2018.
106. Guerriero, C., Cairns, J., Perel, P., Shakur, H., Roberts, I., Collaborators, C.T., Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One, 6(5), 2011, e18987.
107. Lin, Z.X., Woolf, S.K., Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics 39:2 (2016), 119–130.
108. Tuttle, J.R., Ritterman, S.A., Cassidy, D.B., Anazonwu, W.A., Froehlich, J.A., Rubin, L.E., Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J. Arthroplast. 29:8 (2014), 1512–1515.
109. Sucher, M.G., Giordani, M., Figoni, A., Nedopil, A.J., Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid. Int. Orthop. 40:10 (2016), 2019–2023.
110. Harper, R.A., Sucher, M.G., Giordani, M., Nedopil, A.J., Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. Orthopedics 40:6 (2017), e1044–e1049.
111. Gillette, B.P., Maradit Kremers, H., Duncan, C.M., Smith, H.M., Trousdale, R.T., Pagnano, M.W., Sierra, R.J., Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee athroplasty. J. Arthroplast. 28:8 (2013), 137–139.
112. Garcha, P.S., Mohan, C.V., Sharma, R.M., Death after an inadvertent intrathecal injection of tranexamic acid. Anesth. Analg. 104:1 (2007), 241–242.
113. Yeh, H.-M., Lau, H.-P., Lin, P.-L., Sun, W.-Z., Mok, M.S., Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology 98:1 (2003), 270–272.
114. Lin, Z., Xiaoyi, Z., Tranexamic acid-associated seizures: a meta-analysis. Seizure 36 (2016), 70–73.
115. Roberts, I., Perel, P., Prieto-Merino, D., Shakur, H., Coats, T., Hunt, B.J., Lecky, F., Brohi, K., Willett, K., Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ, 345, 2012, e5839.
116. Myles, P.S., Smith, J.A., Forbes, A., Silbert, B., Jayarajah, M., Painter, T., Cooper, D.J., Marasco, S., McNeil, J., Bussières, J.S., Tranexamic acid in patients undergoing coronary-artery surgery. N. Engl. J. Med. 376:2 (2017), 136–148.
117. Ker, K., Edwards, P., Perel, P., Shakur, H., Roberts, I., Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ, 344, 2012, e3054.
118. Tengborn, L., Blombäck, M., Berntorp, E., Tranexamic acid – an old drug still going strong and making a revival. Thromb. Res. 135:2 (2015), 231–242.
119. Hutton, B., Joseph, L., Fergusson, D., Mazer, C.D., Shapiro, S., Tinmouth, A., Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ, 345, 2012, e5798.
120. Martin, K., Wiesner, G., Breuer, T., Lange, R., Tassani, P., The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth. Analg. 107:6 (2008), 1783–1790.
121. Meybohm, P., Herrmann, E., Nierhoff, J., Zacharowski, K., Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid–a meta-analysis of randomised and observational trials of over 30.000 patients. PLoS One, 8(3), 2013, e58009.
122. Martin, K., Knorr, J., Breuer, T., Gertler, R., MacGuill, M., Lange, R., Tassani, P., Wiesner, G., Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid. J. Cardiothorac. Vasc. Anesth. 25:1 (2011), 20–25.
123. Karkouti, K., Wijeysundera, D.N., Yau, T.M., McCluskey, S.A., Tait, G., Beattie, W.S., The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth. Analg. 110:1 (2010), 21–29.
124. Ngaage, D.L., Bland, J.M., Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur. J. Cardiothorac. Surg. 37:6 (2010), 1375–1383.
125. McHugh, S.M., Kolarczyk, L., Lang, R.S., Wei, L.M., Jose, M., Subramaniam, K., A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery. Indian J. Anaesth. 60:2 (2016), 94–101.
126. Shakur, H., Elbourne, D., Gülmezoglu, M., Alfirevic, Z., Ronsmans, C., Allen, E., Roberts, I., The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials, 11(1), 2010, 40.
127. Myles, P.S., Smith, J., Knight, J., Cooper, D.J., Silbert, B., McNeil, J., Esmore, D.S., Buxton, B., Krum, H., Forbes, A., Aspirin and tranexamic acid for coronary artery surgery (ATACAS) trial: rationale and design. Am. Heart J. 155:2 (2008), 224–230.
128. Williams-Johnson, J., McDonald, A., Strachan, G.G., Williams, E., Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. West Indian Med. J. 59:6 (2010), 612–624.
129. Grassin-Delyle, S., Theusinger, O., Albrecht, R., Mueller, S., Spahn, D., Urien, S., Stein, P., Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis. Anaesthesia 73:6 (2018), 719–729.
130. Watts, C., Pagnano, M., Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J. Bone Joint Surg. Br. 94:11_Supple_A (2012), 8–10.
131. Derzon, J. H., Clarke, N., Alford, A., Gross, I., Shander, A., & Thurer, R. (In press). Restrictive Transfusion Strategy, Computerized Physician Order Entry, and Clinical Decision Support Practices for Reducing Overuse of Red Blood Cell Transfusion: A Laboratory Medicine Best Practice Systematic Review and Meta-Analysis. American Journal of Clinical Pathology.